Apella Capital’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
5,285
-53
-1% -$16.7K 0.02% 285
2026
Q1
$1.83M Buy
5,338
+454
+9% +$163K 0.03% 267
2025
Q4
$1.72M Buy
4,884
+4
+0.1% +$1.46K 0.03% 217
2025
Q3
$1.8M Sell
4,880
-47
-1% -$18.2K 0.04% 191
2025
Q2
$1.93M Buy
4,927
+64
+1% +$23.9K 0.05% 169
2025
Q1
$1.77M Buy
4,863
+273
+6% +$104K 0.06% 143
2024
Q4
$1.65M Sell
4,590
-54
-1% -$20K 0.06% 129
2024
Q3
$1.65M Sell
4,644
-21
-0.5% -$7.25K 0.07% 118
2024
Q2
$1.57M Buy
+4,665
New +$1.58M 0.07% 117

Other funds holding SYK

Apella Capital's SYK Position: Q2 2026 in Review

Apella Capital reduced its Stryker (SYK) stake by 0.99% in Q2 2026, selling an estimated $16.7K and leaving 5,285 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #285.

Apella Capital first reported a position in SYK in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.93M in Q2 2025. 522 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Apella Capital held 5,285 shares of Stryker worth $1.74M as of Q2 2026.
  • Apella Capital sold 53 Stryker shares in Q2 2026, an estimated $16.7K.
  • Stryker made up 0.02% of Apella Capital's portfolio in Q2 2026, its #285 holding.
  • Apella Capital first reported a position in Stryker in Q2 2024 and has held it in 9 quarters since.
  • Apella Capital's Stryker position peaked at $1.93M in Q2 2025.
  • 522 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.